tradingkey.logo
tradingkey.logo
Search

Utah Medical Products Inc

UTMD
Add to Watchlist
74.750USD
-0.260-0.35%
Close 09-24 16:00(ET)
237.71MMarket Cap
22.15P/E TTM

Utah Medical Products Inc (UTMD) Revenue Performance

Updated: Jun 30, 2026

Last year, Utah Medical Products Inc generated 19.72M USD for its biggest-performing segment, Gynecology/Electrosurgery/Urology. The United States made the largest contribution, accounting for 22.76M USD last year.

By Business

Annual
Annual
Quarterly
Gynecology/Electrosurgery/Urology
Neonatal
Blood Pressure Monitoring and Accessories
Obstetrics
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Gynecology/Electrosurgery/Urology
19.72M(51.19%)
20.71M(50.62%)
22.30M(44.40%)
21.84M(41.78%)
21.97M(44.79%)
20.55M(48.73%)
25.35M(54.06%)
Neonatal
8.01M(20.79%)
6.87M(16.79%)
6.86M(13.66%)
7.57M(14.47%)
6.69M(13.64%)
5.87M(13.92%)
6.07M(12.93%)
Blood Pressure Monitoring and Accessories
6.79M(17.63%)
9.07M(22.17%)
16.47M(32.79%)
18.21M(34.83%)
15.71M(32.04%)
11.23M(26.63%)
10.48M(22.35%)
Obstetrics
4.00M(10.38%)
4.26M(10.41%)
4.59M(9.14%)
4.66M(8.92%)
4.67M(9.53%)
4.52M(10.72%)
5.00M(10.66%)

By Region

Annual
Annual
Quarterly
United States
Europe
Other
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
United States
22.76M(59.09%)
23.87M(58.36%)
30.41M(60.55%)
34.52M(66.04%)
31.76M(64.74%)
25.87M(61.33%)
27.49M(58.62%)
21.19M(50.46%)
20.29M(48.98%)
19.49M(49.59%)
20.36M(50.71%)
19.48M(47.20%)
18.96M(46.84%)
19.95M(48.03%)
18.85M(49.80%)
Europe
7.93M(20.58%)
8.71M(21.28%)
8.92M(17.76%)
7.21M(13.80%)
7.43M(15.15%)
6.40M(15.17%)
8.91M(18.99%)
9.16M(21.81%)
8.52M(20.57%)
7.99M(20.33%)
7.72M(19.22%)
8.94M(21.66%)
9.08M(22.42%)
9.29M(22.35%)
7.82M(20.66%)
Other
7.83M(20.33%)
8.32M(20.35%)
10.89M(21.69%)
10.54M(20.17%)
9.86M(20.10%)
9.91M(23.50%)
10.51M(22.40%)
11.65M(27.73%)
12.61M(30.45%)
11.82M(30.08%)
12.07M(30.06%)
12.86M(31.14%)
12.45M(30.75%)
12.31M(29.63%)
11.19M(29.55%)
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.